Register Login
Register to leave comments
  • News bot Oct. 28, 2025, 12:33 p.m.

    📋 ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) - Financial Results

    Filing Date: 2025-10-28

    Accepted: 2025-10-28 08:32:02

    Event Type: Financial Results

    Event Details:

    Arcutis Biotherapeutics (ARQT) Reports Q4 2025 Financial Results Arcutis Biotherapeutics (ARQT) announced its financial results for the period ending Q4 2025. Key Financial Highlights:
    • Revenue: 8685
    • Net Income: 7410
    • EPS: $41
    • Cash and equivalents: 47120

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 20.31K 19.66K $657.00 +3.34%
    Current Assets Property Equipment Net 1.22K 1.04K $174.00 +16.71%
    Current Assets Intangible Assets Net 15.38K 9.48K $5.90K +62.20%
    Current Assets Operating Lease Right Of Use Assets 4.57K 1.95K $2.61K +133.85%
    Current Assets Other Assets 596.00 596.00 $0.00 +0.00%
    Current Liabilities Accounts Payable 5.79K 5.79K $0.00 +0.00%
    Current Liabilities Other Long Term Liabilities 360.00 570.00 $-210.00 -36.84%
    Operating Expenses Selling General Administrative 58.82K 195.58K $-136.76K -69.93%
    Other Income Expense Other Income Net 4.18K 6.86K $-2.68K -39.05%
    Other Income Expense Interest Expense -6.65K -9.08K $2.43K +26.75%
    Prepaid Expenses and Other Current Assets 19.66K 19.66K $0.00 +0.00%
    Property and Equipment, Net 1.04K 1.04K $0.00 +0.00%
    Intangible Assets, Net 9.48K 9.48K $0.00 +0.00%
    Other Assets 596.00 596.00 $0.00 +0.00%
    Accounts Payable 14.22K 14.22K $0.00 +0.00%
    Revenue 44.76K 44.76K $0.00 +0.00%
    Selling, General & Administrative 58.82K 195.58K $-136.76K -69.93%
    Loss from Operations -39.07K -30.61K $-8.45K -27.61%
    Other Income, Net 4.18K 6.86K $-2.68K -39.05%
    Interest Expense -6.65K -9.08K $2.43K +26.75%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Arcutis Biotherapeutics
    • CIK: 0001787306
    • Ticker Symbol: ARQT
    • Period End Date: 2025-10-28
    • Document Type: 8-K

Search

News categories